Prokaryotic expression of S2 extracellular domain of SARS coronavirus spike protein and its fusion with Hela cell membrane.
- Author:
Yun LIU
1
;
Ai-Hua LIU
;
Peng DENG
;
Xiang-Ling WU
;
Tao LI
;
Ya-Wei LIU
;
Jia XU
;
Yong JIANG
Author Information
- Publication Type:Journal Article
- MeSH: Escherichia coli; genetics; metabolism; Green Fluorescent Proteins; biosynthesis; genetics; metabolism; HeLa Cells; Humans; Membrane Fusion; drug effects; Membrane Fusion Proteins; biosynthesis; isolation & purification; Membrane Glycoproteins; biosynthesis; genetics; Recombinant Fusion Proteins; biosynthesis; genetics; isolation & purification; SARS Virus; genetics; Spike Glycoprotein, Coronavirus; Viral Envelope Proteins; biosynthesis; genetics
- From: Journal of Southern Medical University 2009;29(3):381-386
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo construct the expression plasmid of S2 extracellular domain (S2ED) of SARS-coronavirus (SARS- Cov) spike protein (S protein) and enhanced green fluorescent protein (EGFP) to obtain the fusion protein expressed in prokaryotic cells.
METHODSS2ED based on bioinformatics prediction and EGFP sequence were amplified by PCR and inserted into pET-14b plasmid. The recombinant protein His-S2ED-EGFP was expressed in E. coli by IPTG induction. After purification by Ni-NTA agarose beads, the soluble fractions of the fusion protein were collected and identified by SDS-PAGE and Western blotting. The fusion of S2ED with Hela cell membranes was observed with fluorescent microscope.
RESULTSThe pET-14b-S2ED-EGFP plasmid was correctly constructed and highly expressed in BL21 (DE3). When incubated with Hela cells, the purified protein could not internalize through membrane fusion.
CONCLUSIONSThe expression plasmid containing S2ED of SARS-Cov S protein and EGFP sequence is constructed successfully. Although the recombinant protein obtained has not shown the expected fusion effect with Hela cell membrane, this work may enrich the understanding of the process of membrane fusion mediated by S2 protein and lay the foundation for future study of targeting cell transport system based on cell-specific binding peptide.